BEARINGPOINT
BearingPoint’s recent study, Digital Leaders 2022, identifies the most successful digital organizations and the common characteristics which lead to their success. The management and technology consultancy found that digital-leading companies focus on the following key themes:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221115006187/en/
BearingPoint’s Digital Leaders Study 2022 outlines what it takes to be a digital leader, and to win in what is a very competitive and uncertain environment (Graphic: Business Wire)
- Customer centricity
- Personalization
- Data centricity
- Innovation
- Ethics and sustainability
BearingPoint assessed 679 companies from 21 sectors in 11 countries, against criteria related to digital product experience, e-commerce, e-CRM, and digital marketing.
The study shows that while much attention is paid to what digital can deliver, digital leadership is hard won, with a massive dependency on getting the execution details right.
Frederic Gigant, Global Leader Customer & Growth at BearingPoint, says: “As new technologies evolve, so does the prescription for being a digital leader. There is no doubt that digitalization has transformed all industries, but there are some – and companies within – who do it better than others. Our Digital Leaders Study 2022 outlines what it takes to be a digital leader, and ultimately, to win in what is a very competitive environment.”
From the industries assessed as part of this study, it is no surprise that Retail scores highest, followed by the Telco, Insurance and Banking industries. Business-to-consumer (B2C) organizations demonstrate some of the highest scores across the dimensions, with overall results showcasing the following findings:
- Digital Marketing – Instagram has now become the most popular platform for advertising across the companies studied, with a score of 94%
- Digital Product Experience – 2 thirds of companies target their audience and display more than 2 different product-related contents accordingly
- E-Commerce – 21% of customer-focused companies (excluding B2B) offer click-and-collect services on the same day, with a total of 42% of companies who offer click-and-collect services
- E-CRM – 87% of companies studied provide customers with access to an online profile where they can input their information, allowing customers to use their data … and companies as well
Frederic Gigant concludes: “There’s no doubt that mastering digital is essential if organizations want to develop long-lasting client relationships and boost revenue. What makes a digital leader naturally changes over time, but our study has highlighted the key themes which are prevalent today; customer centricity, personalization, data centricity, innovation, and ethics and sustainability. These actions – in combination – are what contributes to organizational success.”
The study showed that organizations take these five critical steps to digital leadership:
1. They place customers at the center of their value proposition
For digital leaders, everything starts with customers. They understand them, personalize offering for them, and make them feel special.
2. They generate a positive emotional response through all interactions with their customers and networks
Digital-leading companies focus on the psychological and behavioral, as emotions engendered by a product last longer than the product’s features, however excellent.
3. They deliver value with a suite of advanced technology that synchronizes activities and leverages data centricity
Digital leaders focus on getting ever-better data sets and exploiting them with advanced analytics to provide enhanced experiences and build a more trusted brand.
4. They innovate in all aspects of their ecosystem
Innovation is a constant, ongoing focus for digital-leading companies. It permeates their organization and interactions with their customers, and their broader ecosystem.
5. They integrate ethics, sustainability, and a broad world view in their day-to-day activities
Digital leaders take a stance and use their scale and influence to drive change, while exemplifying sustainable, ethical practice.
To learn more about what makes a digital leader, you can download the Digital Leaders Study 2022 here: https://www.bearingpoint.com/en/insights-events/digital-leaders-2022/
About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.
BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 13,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.
For more information, please visit:
Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221115006187/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 13:00:00 CEST | Press release
– Vimseltinib demonstrated statistically significant and clinically meaningful benefit vs placebo in antitumor response – Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the dura
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 16:09:00 CEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 16:00:00 CEST | Press release
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2%Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary endpoints including pain and functionApplication for marketing authorization under review by China National Medical Products Administration (NMPA), with additional applications planned in the U.S. and other marketsNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the stud
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 15:04:00 CEST | Press release
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Second pivotal development program of povetacicept underway with Phase 2b/3 trial initiation in primary membranous nephropathy - - Updated data from RUBY-3 trial of povetacicept accepted for late breaking oral presentation; inaxaplin study design and APOL1-mediated kidney disease related data accepted for poster presentation - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B c
Qualcomm Announces Quarterly Cash Dividend17.10.2025 15:00:00 CEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom